BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2119828)

  • 1. Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival.
    Omedé P; Boccadoro M; Gallone G; Frieri R; Battaglio S; Redoglia V; Pileri A
    Blood; 1990 Oct; 76(7):1375-9. PubMed ID: 2119828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Ki67 positive lymphocytes in multiple myeloma and benign monoclonal gammopathy.
    Miguel-Garcia A; Matutes E; Tarin F; Garcia-Talavera J; Miguel-Sosa A; Carbonell F; Catovsky D
    J Clin Pathol; 1995 Sep; 48(9):835-9. PubMed ID: 7490317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
    Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
    J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human myeloma: several subsets of circulating lymphocytes express plasma cell-associated antigens.
    Boccadoro M; Omedé P; Massaia M; Dianzani U; Pioppo P; Battaglio S; Meregalli M; Pileri A
    Eur J Haematol; 1988 Apr; 40(4):299-304. PubMed ID: 3366219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of CD4+ CD45R+ T cells in peripheral blood of multiple myeloma patients.
    Serra HM; Mant MJ; Ruether BA; Ledbetter JA; Pilarski LM
    J Clin Immunol; 1988 Jul; 8(4):259-65. PubMed ID: 2970472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum neopterin concentration as indicator of disease severity and poor survival in multiple myeloma.
    Boccadoro M; Battaglio S; Omedè P; Palumbo AP; Fusaro A; Frieri R; Gallone G; Polloni R; Mosso R; De Filippi PG
    Eur J Haematol; 1991 Oct; 47(4):305-9. PubMed ID: 1954991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of RPMI 8226 human myeloma cells by peripheral blood lymphocytes.
    Amano T; Katagiri S; Tominaga N; Oritani K; Tamaki T; Kanayama Y; Yonezawa T; Tarui S
    Acta Haematol; 1992; 87(1-2):37-44. PubMed ID: 1350158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
    Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
    Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
    Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface markers in multiple myeloma.
    Ruiz-Argüelles GJ; San Miguel JF
    Mayo Clin Proc; 1994 Jul; 69(7):684-90. PubMed ID: 8015335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
    Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
    Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer cell frequency and function in patients with monoclonal gammopathies.
    Famularo G; D'Ambrosio A; Quintieri F; Di Giovanni S; Parzanese I; Pizzuto F; Giacomelli R; Pugliese O; Tonietti G
    J Clin Lab Immunol; 1992; 37(3):99-109. PubMed ID: 1285130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in the suppressor-inducer T cell subset in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Shapira R; Froom P; Kinarty A; Aghai E; Lahat N
    Br J Haematol; 1989 Feb; 71(2):223-5. PubMed ID: 2522313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male.
    Kay NE; Bone N; Hupke M; Dalmasso AP
    Blood; 1990 May; 75(10):2024-9. PubMed ID: 2140062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
    Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
    Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of the MB2 monoclonal antibody in paraffin-embedded bone marrow sections of patients with multiple myeloma and monoclonal gammopathy of undetermined significance.
    Dehou MF; Schots R; Lacor P; Arras N; Verhavert P; Klöppel G; van Camp B
    Am J Clin Pathol; 1990 Sep; 94(3):287-91. PubMed ID: 1697732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood lymphocyte subsets in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Tienhaara A; Pelliniemi TT
    Clin Lab Haematol; 1994 Sep; 16(3):213-23. PubMed ID: 7828409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.